|Last Price$61.63||Day Change (%)-0.40%|
|Open Price$61.86||Day Change ($)-0.25|
|Day Range61.29–62.45||52-Week Range44.74–65.63|
As of Fri 3/27/2015 5:00:00 PM | USD
Mylan Launches First and Only Available Intermediate Dosage Strengths of Fentanyl Transdermal System 37.5, 62.5 and 87.5 mcg/hr
Mylan Launches Generic Subutex® Sublingual Tablets
Mylan Completes Acquisition Of Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business
Watson Pharmaceuticals WPI scored big Tuesday when the Food and Drug Administration approved the firm's generic fentanyl patch. We may modestly increase our fair value estimate for Watson and will maintain our fair value estimate for competitor Mylan Laboratories MYL . The pain patch is one of the ...
Berkshire Hathaway, Qualcomm, Mylan in focus
Mylan Files Annual Report on Form 10-K for Year Ended Dec. 31, 2014
UPDATE: Berkshire Hathaway, Qualcomm, Mylan in focus
Mylan fourth-quarter earnings in-line with Street
Mylan Laboratories MYL reported impressive second-quarter results Wednesday. However, most of the improvement was temporary and will not affect our fair value estimate. The quarter was only slightly better than we expected after excluding a one-time litigation payment and proceeds from a product ...
Product durability, diversification, and cost synergies support strong earnings growth for this undervalued wide-moat firm.